Device Trial Radar · NCT06872905
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
158
Planned (sponsor's estimate)
Start
May 30, 2025
Primary completion
Aug 16, 2027
Study completion Aug 16, 2027
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 12, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).
Conditions
- Aortoiliac Occlusive Disease
Interventions
GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)Device
Treatment of Target Lesions with the VBX Device in the aortic and common iliac positions during the CERAB procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness Endpoint: 1-Year Primary patency (hypothesis testing)Time frame: 1-Year
1 more outcomes with a free account
Locations
27 sites in 5 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
26 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.